These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3490498)

  • 81. Dysprosody following acquired neurogenic impairment.
    Hird K; Kirsner K
    Brain Lang; 1993 Jul; 45(1):46-60. PubMed ID: 8353729
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Motor speech disorders: a clinical approach.
    Tepperman PS; Thacker RC
    Postgrad Med; 1980 Jul; 68(1):86-9, 92-5, 97. PubMed ID: 7393786
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Patterns of dysarthric movement in patients with amyotrophic lateral sclerosis and pseudobulbar palsy.
    Hirose H; Kiritani S; Sawashima M
    Folia Phoniatr (Basel); 1982; 34(2):106-12. PubMed ID: 7129273
    [No Abstract]   [Full Text] [Related]  

  • 84. Speech motor programming in hypokinetic and ataxic dysarthria.
    Spencer KA; Rogers MA
    Brain Lang; 2005 Sep; 94(3):347-66. PubMed ID: 16098382
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of speaking rate manipulations on acoustic and perceptual aspects of the dysarthria in amyotrophic lateral sclerosis.
    Weismer G; Laures JS; Jeng JY; Kent RD; Kent JF
    Folia Phoniatr Logop; 2000; 52(5):201-19. PubMed ID: 10965174
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Positron emission tomography and basal ganglia functions].
    Kato M
    No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633
    [No Abstract]   [Full Text] [Related]  

  • 87. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Belakhlef A; Mandel F; Przedborski S; Fahn S
    Neurology; 1995 Nov; 45(11):1995-2004. PubMed ID: 7501148
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Acoustic analysis of speech timing in Huntington's disease.
    Hertrich I; Ackermann H
    Brain Lang; 1994 Aug; 47(2):182-96. PubMed ID: 7953613
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a "rhythm disorder"?
    Skodda S; Flasskamp A; Schlegel U
    J Neural Transm (Vienna); 2010 May; 117(5):605-12. PubMed ID: 20238130
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Speech disorders in Parkinson's disease].
    Arefyeva AP; Skripkina NA; Vasenina EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):32-36. PubMed ID: 31825387
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.
    Rusz J; Megrelishvili M; Bonnet C; Okujava M; Brožová H; Khatiashvili I; Sekhniashvili M; Janelidze M; Tolosa E; Růžička E
    J Neural Transm (Vienna); 2014 Jun; 121(6):655-64. PubMed ID: 24445755
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sync Pending: Characterizing Conversational Entrainment in Dysarthria Using a Multidimensional, Clinically Informed Approach.
    Borrie SA; Barrett TS; Liss JM; Berisha V
    J Speech Lang Hear Res; 2020 Jan; 63(1):83-94. PubMed ID: 31855608
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Speech characteristics in individuals with myasthenia gravis: a case control study.
    Ayres A; Winckler PB; Jacinto-Scudeiro LA; Rech RS; Padovani MMP; Jotz GP; Olchik MR
    Logoped Phoniatr Vocol; 2022 Apr; 47(1):35-42. PubMed ID: 33106062
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Accelerated speech in dysarthria after acquired brain injury: acoustic correlates.
    Ziegler W; Hoole P; Hartmann E; von Cramon D
    Br J Disord Commun; 1988 Dec; 23(3):215-28. PubMed ID: 3267417
    [No Abstract]   [Full Text] [Related]  

  • 100. Spinal Cord Stimulation Improved Freezing of Gait and Hypokinetic Dysarthria of a Patient with Dopamine-Resistant Multiple System Atrophy-Parkinsonian Type.
    Gong H; Liu Y; Zhu X; Gong X
    Neurol India; 2022; 70(2):757-759. PubMed ID: 35532653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.